Home›Stock Screener›Kwality Pharmaceuticals›Quarterly Results

Kwality Pharmaceuticals Quarterly Results

Latest Quarter Net Profit
₹25 Cr
QMar 2026
Quarterly Results

Kwality Pharmaceuticals quarterly results. In Mar 2026, Kwality Pharmaceuticals (KPL) reported revenue ₹158 Cr and net profit ₹25 Cr — revenue +35.0% YoY. Check KPL market value to track the company's total market size over time.

KPL Quarterly Results — Revenue, Profit & EPS Highlights

Kwality Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Kwality Pharmaceuticals share price chart.

  • Revenue of ₹158 Cr in Mar 2026 (-3.1% vs Jun 2026, +35.0% vs Mar 2025)
  • Net Profit of ₹25 Cr in Mar 2026 (-3.8% vs Jun 2026, +66.7% vs Mar 2025)
  • EBITDA of ₹40 Cr in Mar 2026 (-4.8% vs Jun 2026)
  • Operating Margin of 25.0% in Mar 2026 (+0.0pp vs Jun 2026)
  • Earnings Per Share of ₹24.39 in Mar 2026 (-1.2% vs Jun 2026)

Kwality Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

KPL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 158 163 112 117 112 -3.1% 35.0%
Net Profit (₹ Cr) 25 26 14 15 12 - -
EBITDA (₹ Cr) 40 42 26 27 25 - -
EPS (₹) 24.39 24.69 13.60 13.95 11.49 - -
Operating Margin (%) 25.0% 25.0% 23.0% 22.0% 22.0% - -

KPL Share Price Trend — 1-Year Movement Across Quarterly Results

Kwality Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review KPL earnings valuation to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 15.8%
EBITDA Margin 25.3%
Operating Margin 25.0%
ROE (Annual) 30.3%

Balance Sheet Highlights

Total Assets ₹592 Cr
Total Equity ₹330 Cr
Current Assets ₹406 Cr
Current Liabilities ₹37 Cr

Cash Flow Analysis

Operating Cash Flow ₹17 Cr
Investing Cash Flow ₹-35 Cr
Financing Cash Flow ₹7 Cr
Net Cash Flow ₹-11 Cr

Current Market Data

Current Price ₹3644.20
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 117
Sept 2025 112
Jun 2026 163
Mar 2026 158

Net Profit Trend (₹ Cr)

Mar 2025 15
Sept 2025 14
Jun 2026 26
Mar 2026 25

Operating Margin Trend (%)

Mar 2025 22.0%
Sept 2025 23.0%
Jun 2026 25.0%
Mar 2026 25.0%

KPL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Kwality Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores